Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 2000 Dec;125(3):701–704. doi: 10.1017/s095026880000491x

Prevalence of hepatitis B anti-core antibody in the Republic of Ireland.

T O'Connell 1, L Thornton 1, D O'Flanagan 1, A Staines 1, J Connell 1, S Dooley 1, G McCormack 1
PMCID: PMC2869653  PMID: 11218220

Abstract

The aim of this study was to estimate the prevalence of hepatitis B exposure in the population of the Republic of Ireland, by measuring the prevalence of hepatitis B anti-core antibody in oral fluid collected by postal survey. A random multi-stage stratified sample of Irish households was obtained, using the Irish electoral register as the sampling frame. A total of 962 households were selected, and a household response rate of 60.4% was achieved. Oral fluid specimens totalling 1714 were tested for antibody to hepatitis B core antigen (anti-HBc), using an Immune Capture Enzyme Immuno-Assay. Five specimens (0.29%) were found to contain anti-HBc. Adjusting for study design, the estimated anti-HBc prevalence in the Republic of Ireland is 0.51%. This study demonstrates that self-collection of oral fluid samples is acceptable to the public, and based upon the data generated, that the Republic of Ireland has a low prevalence of hepatitis B infection.

Full Text

The Full Text of this article is available as a PDF (121.3 KB).


Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES